Testing effectiveness (Phase 2)Study completedNCT00559052
What this trial is testing
An Open-Label Study to Evaluate the Intraduodenal Delivery of Enzymes From Administration of VIOKASE16 in Exocrine Pancreatic Insufficiency (EPI)
Who this might be right for
Exocrine Pancreatic Insufficiency
Axcan Pharma 22